Tom Stack-Babich

HaemaLogiX Pty Ltd. is a biotech company located in Sydney, Australia. The Australian company has a wide range and depth of experience in antibody research, nonclinical & clinical development, manufacturing, and commercialization. The scientific advisory board members are internationally recognized experts in monoclonal antibody therapies and hematology. The company's current research and clinical trial partners are leaders in multiple myeloma and AL amyloidosis therapy. Founded in 2014, the company is researching immune-based treatments such as monoclonal antibodies, CAR T cell therapies, and bispecific antibodies to target unique antigens on malignant cells and improve the quality of life of patients suffering from blood cancers like multiple myeloma and other life-threatening diseases like AL amyloidosis. Bryce D. Carmine has been the CEO of the company since 2015.

Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets.

MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom.

Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD.

New Beginnings Acquisition Corp. III operates as a blank check company. The company was founded by Michael S. Liebowitz and Russell W. Galbut on January 19, 2021 and is headquartered in Miami Beach, Florida.

New Beginnings Acquisition Corp. II operates as a blank check company. The company was founded by Michael S. Liebowitz and Russell W. Galbut on January 19, 2021 and is headquartered in Miami Beach, FL.

Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA.

Riverside Partners LLC (Riverside Partners) is a private equity firm founded in 1989. The firm is headquartered in Boston, Massachusetts.

Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York.

TPG Sixth Street Partners LLC (TPG Sixth Street Partners) is a private equity and venture capital firm founded in 2009 by Alan Samuel Waxman and Joshua William Easterly. The firm is headquartered in San Francisco, California.

Founded in 1998, ProQuest Investments Canada is a healthcare venture capital firm located in Montreal. The firm is Canadian investment arm of US-based ProQuest Investments

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA.

Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

Mt. Cook Pharma, Inc. provides treatment for urological diseases. It offers services to overactive bladder, lower urinary symptoms, and interstitial cystitis diseases. The company was headquartered in Princeton, NJ.

Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA.

Rockwell Transportation, Inc. engages in arrangement of freight and cargo transportation services. The company is headquartered in Wixom, MI.

Bond Biosciences, Inc. engages in healthcare business. It focuses on small developing molecule based therapeutics for preventing iron absorption. The company is headquartered in New York, NY.

ProSanos Corp. develops and provides healthcare solutions for the pharmaceutical and biotechnology industries. The company was founded by Jonathan A. Morris and Michael N. Liebman in 2000 and is headquartered in Harrisburg, PA.

Cycle Pharmaceuticals Ltd. is a privately-owned biotechnology company headquartered in Cambridge, UK. The British company focuses on rare metabolic, immunological, and neurological genetic conditions, including multiple sclerosis. Cycle Pharmaceuticals utilizes the latest pharmaceutical technologies to provide superior drug treatments and individualized patient support services. Cycle Pharmaceuticals Ltd. was founded in 2012 with the aim of delivering drug treatments and services to the under-served rare disease patient community. James Alexander Harrison has been the CEO of the company since 2012.

Iota Biosciences, Inc. provides biotechnological research and development services. The company was founded by Richard Passov, Coleman Fung and Tim Opler in 2017 and is headquartered in Berkeley, CA.

Health Outlook Corp. is a health prediction company that uses modern proteomics to better predict health events and improve health outcomes. The company is based in New York, NY. The company's proprietary algorithms use statistical models of mortality risk that incorporate traditional factors and modern proteomic markers. Health Outlook is launching businesses that leverage its algorithms in the financial services and health systems markets. Health Outlook was founded by Tim Opler, and the CEO is Howard W. Sams.